DVS
Subscribe
Sign in
Home
Notes
Now
Tools
Archive
About
Latest
Top
Discussions
October News
Rough diamonds radio hubbub
Oct 7
•
David Van Sickle
9
February 2025
Revisiting What We Missed in Landmark Epidemiological Studies
Hunting for overlooked insights in their findings and datasets with the latest AI tools
Feb 18
•
David Van Sickle
1
May 2024
London highlights & May favorites
Plus, companies as creative acts, and promising new respiratory drugs
May 31, 2024
•
David Van Sickle
4
4
Human curiosity as AI naturalist guide
Perplexing observations and productive holes in science
May 7, 2024
•
David Van Sickle
4
April 2024
Healthtech vs Pulmonary Fibrosis
A quick profile of two companies working on IPF/PF
Apr 18, 2024
•
David Van Sickle
1
Respiratory Healthtech Companies
An informal inventory of what's in the market today
Apr 3, 2024
•
David Van Sickle
1
March 2024
Equity Prerequisite
Demands for accessible and equitable digital respiratory health are premature and counterproductive
Mar 4, 2024
•
David Van Sickle
6
1
February 2024
Stuff making it feel like spring in February
Seriously, it is 50+ degrees here and the ice is almost gone
Feb 9, 2024
•
David Van Sickle
2
January 2024
Digital Health vs the Causes of Incidence
We need comparative research at scale to move things forward
Jan 23, 2024
•
David Van Sickle
4
3
December 2023
Digital health mafia departures
Making sense of company identity and individual careers
Dec 13, 2023
•
David Van Sickle
5
November 2023
Art, technology, and health
Remembering Beatriz da Costa and PigeonBlog
Nov 22, 2023
•
David Van Sickle
2
1
September 2023
Waterfall Charts; September favorites
People, music, writing and some legendary Excel
Sep 29, 2023
•
David Van Sickle
3
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts